Cargando…
DNA methylation changes in biomarker loci occur early in cancer progression
Tumor-specific DNA methylation can be used for cancer diagnostics and monitoring. We have recently reported a set of DNA methylation biomarkers that can distinguish plasma samples from lung cancer patients versus healthy controls with high sensitivity and specificity. Furthermore, the DNA methylat...
Autores principales: | Vrba, Lukas, Futscher, Bernard W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993824/ https://www.ncbi.nlm.nih.gov/pubmed/32047604 http://dx.doi.org/10.12688/f1000research.21584.2 |
Ejemplares similares
-
Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes
por: Vrba, Lukas, et al.
Publicado: (2017) -
miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer
por: Vrba, Lukas, et al.
Publicado: (2013) -
DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients
por: Vrba, Lukas, et al.
Publicado: (2019) -
DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage
por: Watts, George S, et al.
Publicado: (2008) -
Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation
por: Severson, Paul L., et al.
Publicado: (2012)